List of Tables
Table 1. Global Nuclear Medicine Imaging Agents Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Nuclear Medicine Imaging Agents Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Nuclear Medicine Imaging Agents Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nuclear Medicine Imaging Agents Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Nuclear Medicine Imaging Agents Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Nuclear Medicine Imaging Agents Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Nuclear Medicine Imaging Agents Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Nuclear Medicine Imaging Agents Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Nuclear Medicine Imaging Agents, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Nuclear Medicine Imaging Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nuclear Medicine Imaging Agents, Product Type & Application
Table 12. Global Key Manufacturers of Nuclear Medicine Imaging Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nuclear Medicine Imaging Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Imaging Agents as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nuclear Medicine Imaging Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nuclear Medicine Imaging Agents Sales by Region (2018-2023) & (K Units)
Table 18. Global Nuclear Medicine Imaging Agents Sales Market Share by Region (2018-2023)
Table 19. Global Nuclear Medicine Imaging Agents Sales by Region (2024-2029) & (K Units)
Table 20. Global Nuclear Medicine Imaging Agents Sales Market Share by Region (2024-2029)
Table 21. Global Nuclear Medicine Imaging Agents Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Nuclear Medicine Imaging Agents Revenue Market Share by Region (2018-2023)
Table 23. Global Nuclear Medicine Imaging Agents Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nuclear Medicine Imaging Agents Revenue Market Share by Region (2024-2029)
Table 25. North America Nuclear Medicine Imaging Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nuclear Medicine Imaging Agents Sales by Country (2018-2023) & (K Units)
Table 27. North America Nuclear Medicine Imaging Agents Sales by Country (2024-2029) & (K Units)
Table 28. North America Nuclear Medicine Imaging Agents Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Nuclear Medicine Imaging Agents Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nuclear Medicine Imaging Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nuclear Medicine Imaging Agents Sales by Country (2018-2023) & (K Units)
Table 32. Europe Nuclear Medicine Imaging Agents Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nuclear Medicine Imaging Agents Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Nuclear Medicine Imaging Agents Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nuclear Medicine Imaging Agents Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nuclear Medicine Imaging Agents Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Nuclear Medicine Imaging Agents Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nuclear Medicine Imaging Agents Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Nuclear Medicine Imaging Agents Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nuclear Medicine Imaging Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nuclear Medicine Imaging Agents Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Nuclear Medicine Imaging Agents Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nuclear Medicine Imaging Agents Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Nuclear Medicine Imaging Agents Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nuclear Medicine Imaging Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nuclear Medicine Imaging Agents Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Nuclear Medicine Imaging Agents Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nuclear Medicine Imaging Agents Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Nuclear Medicine Imaging Agents Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nuclear Medicine Imaging Agents Sales (K Units) by Type (2018-2023)
Table 51. Global Nuclear Medicine Imaging Agents Sales (K Units) by Type (2024-2029)
Table 52. Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2018-2023)
Table 53. Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2024-2029)
Table 54. Global Nuclear Medicine Imaging Agents Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Nuclear Medicine Imaging Agents Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2018-2023)
Table 57. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2024-2029)
Table 58. Global Nuclear Medicine Imaging Agents Price (US$/Unit) by Type (2018-2023)
Table 59. Global Nuclear Medicine Imaging Agents Price (US$/Unit) by Type (2024-2029)
Table 60. Global Nuclear Medicine Imaging Agents Sales (K Units) by Application (2018-2023)
Table 61. Global Nuclear Medicine Imaging Agents Sales (K Units) by Application (2024-2029)
Table 62. Global Nuclear Medicine Imaging Agents Sales Market Share by Application (2018-2023)
Table 63. Global Nuclear Medicine Imaging Agents Sales Market Share by Application (2024-2029)
Table 64. Global Nuclear Medicine Imaging Agents Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Nuclear Medicine Imaging Agents Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2018-2023)
Table 67. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2024-2029)
Table 68. Global Nuclear Medicine Imaging Agents Price (US$/Unit) by Application (2018-2023)
Table 69. Global Nuclear Medicine Imaging Agents Price (US$/Unit) by Application (2024-2029)
Table 70. GE HealthCare Corporation Information
Table 71. GE HealthCare Description and Business Overview
Table 72. GE HealthCare Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. GE HealthCare Nuclear Medicine Imaging Agents Product
Table 74. GE HealthCare Recent Developments/Updates
Table 75. Bracco Diagnostic Corporation Information
Table 76. Bracco Diagnostic Description and Business Overview
Table 77. Bracco Diagnostic Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Bracco Diagnostic Nuclear Medicine Imaging Agents Product
Table 79. Bracco Diagnostic Recent Developments/Updates
Table 80. Guerbet Corporation Information
Table 81. Guerbet Description and Business Overview
Table 82. Guerbet Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Guerbet Nuclear Medicine Imaging Agents Product
Table 84. Guerbet Recent Developments/Updates
Table 85. Mallinckrodt Corporation Information
Table 86. Mallinckrodt Description and Business Overview
Table 87. Mallinckrodt Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Mallinckrodt Nuclear Medicine Imaging Agents Product
Table 89. Mallinckrodt Recent Developments/Updates
Table 90. Lantheus Corporation Information
Table 91. Lantheus Description and Business Overview
Table 92. Lantheus Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Lantheus Nuclear Medicine Imaging Agents Product
Table 94. Lantheus Recent Developments/Updates
Table 95. Yantai Dongcheng Corporation Information
Table 96. Yantai Dongcheng Description and Business Overview
Table 97. Yantai Dongcheng Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Yantai Dongcheng Nuclear Medicine Imaging Agents Product
Table 99. Yantai Dongcheng Recent Developments/Updates
Table 100. Foshan Rui Diao Pharmaceutical Corporation Information
Table 101. Foshan Rui Diao Pharmaceutical Description and Business Overview
Table 102. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product
Table 104. Foshan Rui Diao Pharmaceutical Recent Developments/Updates
Table 105. Cardinal Health Corporation Information
Table 106. Cardinal Health Description and Business Overview
Table 107. Cardinal Health Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Cardinal Health Nuclear Medicine Imaging Agents Product
Table 109. Cardinal Health Recent Developments/Updates
Table 110. Blue Earth Diagnostics Corporation Information
Table 111. Blue Earth Diagnostics Description and Business Overview
Table 112. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product
Table 114. Blue Earth Diagnostics Recent Developments/Updates
Table 115. Bayer AG Corporation Information
Table 116. Bayer AG Description and Business Overview
Table 117. Bayer AG Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bayer AG Nuclear Medicine Imaging Agents Product
Table 119. Bayer AG Recent Developments/Updates
Table 120. Abx Advanced Biochemical Corporation Information
Table 121. Abx Advanced Biochemical Description and Business Overview
Table 122. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product
Table 124. Abx Advanced Biochemical Recent Developments/Updates
Table 125. Eli Lilly and Company Corporation Information
Table 126. Eli Lilly and Company Description and Business Overview
Table 127. Eli Lilly and Company Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Eli Lilly and Company Nuclear Medicine Imaging Agents Product
Table 129. Eli Lilly and Company Recent Developments/Updates
Table 130. Jubilant Pharma Limited Corporation Information
Table 131. Jubilant Pharma Limited Description and Business Overview
Table 132. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product
Table 134. Jubilant Pharma Limited Recent Developments/Updates
Table 135. Navidea Corporation Information
Table 136. Navidea Description and Business Overview
Table 137. Navidea Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Navidea Nuclear Medicine Imaging Agents Product
Table 139. Navidea Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Nuclear Medicine Imaging Agents Distributors List
Table 143. Nuclear Medicine Imaging Agents Customers List
Table 144. Nuclear Medicine Imaging Agents Market Trends
Table 145. Nuclear Medicine Imaging Agents Market Drivers
Table 146. Nuclear Medicine Imaging Agents Market Challenges
Table 147. Nuclear Medicine Imaging Agents Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nuclear Medicine Imaging Agents
Figure 2. Global Nuclear Medicine Imaging Agents Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Nuclear Medicine Imaging Agents Market Share by Type in 2022 & 2029
Figure 4. Fluorine 18 Labeling Product Picture
Figure 5. Carbon 11 Labeling Product Picture
Figure 6. Nitrogen 13 Labeling Product Picture
Figure 7. Oxygen 15 Labeling Product Picture
Figure 8. Technetium 99 Labeling Product Picture
Figure 9. Others Product Picture
Figure 10. Global Nuclear Medicine Imaging Agents Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Nuclear Medicine Imaging Agents Market Share by Application in 2022 & 2029
Figure 12. Early Diagnosis
Figure 13. Clinical Stage
Figure 14. Treatment Evaluation
Figure 15. Global Nuclear Medicine Imaging Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Nuclear Medicine Imaging Agents Market Size (2018-2029) & (US$ Million)
Figure 17. Global Nuclear Medicine Imaging Agents Sales (2018-2029) & (K Units)
Figure 18. Global Nuclear Medicine Imaging Agents Average Price (US$/Unit) & (2018-2029)
Figure 19. Nuclear Medicine Imaging Agents Report Years Considered
Figure 20. Nuclear Medicine Imaging Agents Sales Share by Manufacturers in 2022
Figure 21. Global Nuclear Medicine Imaging Agents Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Nuclear Medicine Imaging Agents Players: Market Share by Revenue in 2022
Figure 23. Nuclear Medicine Imaging Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Nuclear Medicine Imaging Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Nuclear Medicine Imaging Agents Sales Market Share by Country (2018-2029)
Figure 26. North America Nuclear Medicine Imaging Agents Revenue Market Share by Country (2018-2029)
Figure 27. United States Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Nuclear Medicine Imaging Agents Sales Market Share by Country (2018-2029)
Figure 30. Europe Nuclear Medicine Imaging Agents Revenue Market Share by Country (2018-2029)
Figure 31. Germany Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Nuclear Medicine Imaging Agents Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Nuclear Medicine Imaging Agents Revenue Market Share by Region (2018-2029)
Figure 38. China Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Nuclear Medicine Imaging Agents Sales Market Share by Country (2018-2029)
Figure 46. Latin America Nuclear Medicine Imaging Agents Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Colombia Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Nuclear Medicine Imaging Agents Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Nuclear Medicine Imaging Agents Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Nuclear Medicine Imaging Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Nuclear Medicine Imaging Agents by Type (2018-2029)
Figure 57. Global Revenue Market Share of Nuclear Medicine Imaging Agents by Type (2018-2029)
Figure 58. Global Nuclear Medicine Imaging Agents Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Nuclear Medicine Imaging Agents by Application (2018-2029)
Figure 60. Global Revenue Market Share of Nuclear Medicine Imaging Agents by Application (2018-2029)
Figure 61. Global Nuclear Medicine Imaging Agents Price (US$/Unit) by Application (2018-2029)
Figure 62. Nuclear Medicine Imaging Agents Value Chain
Figure 63. Nuclear Medicine Imaging Agents Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
